Article
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
Leukemia - 1 Sept 2013
Geyh S, Oz S, Cadeddu R-P, Fröbel J, Brückner B, Kündgen A, Fenk R, Bruns I, Zilkens C, Hermsen D, Gattermann N, Kobbe G, Germing U, Lyko F, Haas R, Schroeder T
Abstract excerpt
Ineffective hematopoiesis is a major characteristic of myelodysplastic syndromes (MDS) causing relevant morbidity and mortality. Mesenchymal stromal cells (MSC) have been shown to physiologically support hematopoiesis, but their contribution to the pathogenesis of MDS remains elusive. We show that MSC from patients across all MDS subtypes (n=106) exhibit significantly reduced growth and proliferative capacities...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.